Open access
Open access
Powered by Google Translator Translator

Daily Archives: February 28, 2023

WHO Report | A woman dies every two minutes due to pregnancy or childbirth

28 Feb, 2023 | 14:04h | UTC

Summary: This new report by United Nations agencies shows that a woman dies every two minutes due to pregnancy or childbirth. The report covers maternal deaths from 2000 to 2020 and reveals that maternal deaths either increased or stagnated in nearly all regions of the world, with some regions experiencing major setbacks. The poorest parts of the world and countries affected by conflict continue to have the highest rates of maternal deaths. Severe bleeding, high blood pressure, pregnancy-related infections, complications from unsafe abortion, and underlying conditions aggravated by pregnancy are the leading causes of maternal deaths, which are largely preventable and treatable with access to high-quality healthcare. The COVID-19 pandemic may have further held back progress on maternal health. The report calls for urgent action to ensure every woman and girl has access to critical health services before, during, and after childbirth, so they can fully exercise their reproductive rights.

News Release: A woman dies every two minutes due to pregnancy or childbirth: UN agencies – World Health Organization

Report: Trends in maternal mortality 2000 to 2020: estimates by WHO, UNICEF, UNFPA, World Bank Group and UNDESA/Population Division – World Health Organization

Commentaries:

Ambitious goal to slash maternal deaths in jeopardy – Nature

U.N.: Progress on reducing global maternal mortality has stalled since 2015 – STAT

Eight Hundred Women Die Every Day During Pregnancy or Childbirth – Health Policy Watch

 


Choosing Wisely in Cardiology | New ACC list of five things physicians and patients should question

28 Feb, 2023 | 14:03h | UTC

Summary: The American College of Cardiology (ACC) has released a list of “Five Things Physicians and Patients Should Question” in cardiology as part of the Choosing Wisely campaign, which encourages conversations between clinicians and patients about potentially unnecessary tests, treatments, and procedures. The list includes recommendations to:

  1. Avoid the routine use of invasive hemodynamic monitoring with pulmonary artery catheters in patients with uncomplicated acute decompensated heart failure.
  2. Avoid performing atrial fibrillation ablation for the sole purpose of discontinuing chronic anticoagulation.
  3. Avoid routine imaging stress tests or coronary CT angiography for the workup of palpitations or presyncope.
  4. Avoid obtaining a coronary artery calcium score in patients with known clinical atherosclerotic cardiovascular disease.
  5. Avoid obtaining routine serial echocardiograms for chronic heart failure if there has been no change in signs, symptoms, or management.

The recommendations are based on published national guidelines and aim to broadly represent the field of cardiology.

List: American College of Cardiology: Five Things Physicians and Patients Should Question – Choosing Wisely

Commentary: ACC Releases New List of Choosing Wisely Recommendations – American College of Cardiology

See complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada

 


Review | Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management

28 Feb, 2023 | 14:00h | UTC

Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management – The BMJ

 


Physicians are more burned out than ever — here’s what can be done about it

28 Feb, 2023 | 13:57h | UTC

Physicians Are More Burned Out Than Ever—Here’s What Can Be Done About It – JAMA (free for a limited period)

Related Report: Addressing Health Worker Burnout – The U.S. Surgeon General’s Advisory on Building a Thriving Health Workforce

Related:

AAP Clinical Report | Physician health and wellness.

M-A | Physicians suffering burnout are twice as likely to be involved in patient safety incidents.

Systematic Review | Predictors of burnout among healthcare providers.

Prevalence of burnout among GPs: a systematic review and meta-analysis – British Journal of General Practice

Physician Well-being 2.0: Where Are We and Where Are We Going? – Mayo Clinic Proceedings

Consensus Study – Taking Action Against Clinician Burnout: A Systems Approach to Professional Well-Being – National Academies of Medicine

Consensus Study – Taking Action Against Clinician Burnout: A Systems Approach to Professional Well-Being – National Academies of Medicine

Assessment of Risk Factors for Suicide Among US Health Care Professionals

Beyond Burnout: Docs Decry ‘Moral Injury’ From Financial Pressures of Health Care

Hospital administration response to physician stress and burnout – Journal of Hospital Practice

Opinion: It’s Time to Talk About Physician Burnout and Moral Injury

Systematic Review: Effect of Organization-Directed Workplace Interventions on Physician Burnout

The 3 Causes Of Physician Burnout (And Why There’s No Simple Solution) – Forbes

Physician Burnout: A Global Crisis

The Burnout Crisis in American Medicine – The Atlantic

To Combat Physician Burnout and Improve Care, Fix the Electronic Health Record – Harvard Business Review

Physician burnout costs up to $17B a year, task force says – HealthcareDive

Systematic Review: Prevalence of Burnout Among Physicians

Prevalence of Burnout in Medical and Surgical Residents: A Meta-Analysis – International Journal of Environmental Research and Public Health

Association Between Physician Burnout and Patient Safety, Professionalism, and Patient Satisfaction

 


M-A | Which adverse events and which drugs are implicated in drug-related hospital admissions

28 Feb, 2023 | 13:59h | UTC

Summary: This systematic review and meta-analysis aimed to provide an updated estimation of drug-related hospital admissions, the types and frequency of drug-induced harm, and the drugs involved. The review included 17 studies that examined acute admissions to emergency departments or inpatient wards resulting from drug-induced harm in the general population. These studies were published between January 2012 and December 2021. The estimated rates of admissions resulting from adverse drug reactions* (ADRs) and adverse drug events* (ADEs) were 8.3% and 13.9%, respectively. Almost half of the admissions related to ADRs and over two-thirds of those related to ADEs were possibly preventable. Gastrointestinal disorders, electrolyte disturbances, bleeding events, and renal and urinary disorders were the most frequently involved categories of drug-induced harm. The most frequently involved drug groups were nervous system drugs, followed by cardiovascular and antithrombotic agents.

*Adverse drug events (ADEs) and adverse drug reactions (ADRs) are two terms that are often used interchangeably, but they actually have different meanings. Adverse drug events (ADEs) refer to any negative effect that results from medication exposure and can be caused by a variety of factors, including medication errors, overdose, drug interactions, or allergic reactions. In contrast, adverse drug reactions (ADRs) are a specific type of ADE that occur as unintended effects of medication at normal therapeutic doses.

Article: Which Adverse Events and Which Drugs Are Implicated in Drug-Related Hospital Admissions? A Systematic Review and Meta-Analysis – Journal of Clinical Medicine

 


Perspective | Gender dysphoria in young people is rising — and so is professional disagreement

28 Feb, 2023 | 13:55h | UTC

Gender dysphoria in young people is rising—and so is professional disagreement – The BMJ

News Release: Gender dysphoria is rising—and so is professional disagreement – BMJ Newsroom

 

Commentary on Twitter

 


RCT | 2-y outcomes confirm the harms caused by high prophylactic platelet transfusion thresholds in preterm infants

28 Feb, 2023 | 13:53h | UTC

Summary: The study investigated the long-term outcomes of preterm infants who participated in a randomized trial of platelet transfusions at different threshold levels. Infants with platelet counts below 50×109/L were enrolled and randomized to either a higher threshold of 50×109/L or a lower threshold of 25×109/L. The study found that infants randomized to the higher threshold had a higher rate of death or significant neurodevelopmental impairment at a corrected age of 2 years compared to the lower threshold group. The study further supports evidence of harm caused by high prophylactic platelet transfusion thresholds in preterm infants. The mechanisms by which platelet transfusions could mediate harmful effects remain unknown, but the study identified increased rates of intraventricular hemorrhage and bronchopulmonary dysplasia in the higher threshold group, which may contribute to the adverse outcomes observed.

Article: Two-year outcomes following a randomised platelet transfusion trial in preterm infants – ADC Fetal & Neonatal

Original Study: Randomized Trial: Platelet-Transfusion Thresholds in Neonates

 

Commentary from the author on Twitter (thread – click for more)

 


AAP Policy Statement | Crowding in the emergency department: challenges and recommendations for the care of children

28 Feb, 2023 | 13:50h | UTC

Guideline: Crowding in the Emergency Department: Challenges and Recommendations for the Care of Children – Pediatrics

Technical Report: Crowding in the Emergency Department: Challenges and Best Practices for the Care of Children – Pediatrics

News Release: Crowding in the ED: AAP guidance offers solutions to complex problem – American Academy of Pediatrics

 


Perspective | The inertia of clinical trials and unethical control arms in oncology

28 Feb, 2023 | 13:51h | UTC

The inertia of clinical trials and unethical control arms – Sensible Medicine

 


Guidelines | Efficacy and safety of non-steroidal anti-inflammatory drugs for the treatment of acute pain after orthopedic trauma

28 Feb, 2023 | 13:48h | UTC

Efficacy and safety of non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment of acute pain after orthopedic trauma: a practice management guideline from the Eastern Association for the Surgery of Trauma and the Orthopedic Trauma Association – Trauma Surgery & Acute Care Open

 


M-A | Application of enhanced recovery after surgery in partial nephrectomy for renal tumors

28 Feb, 2023 | 13:46h | UTC

Application of enhanced recovery after surgery in partial nephrectomy for renal tumors: A systematic review and meta-analysis – Frontiers in Oncology

Related:

Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines

Top 100 Most-Cited Articles on Enhanced Recovery After Surgery: A Bibliometric Analysis and Visualized Study – Frontiers in Surgery

 


Unique considerations for patient retention in decentralized clinical trials

28 Feb, 2023 | 13:43h | UTC

Unique Considerations for Patient Retention in Decentralized Clinical Trials – The Association of Clinical Research Professionals

 


Fatal accident calls MRI safety standards into question—are more regulations needed?

28 Feb, 2023 | 13:44h | UTC

Fatal accident calls MRI safety standards into question—are more regulations needed? – Health Imaging

 


Review | Embracing complexity: making sense of diet, nutrition, obesity and type 2 diabetes

28 Feb, 2023 | 13:42h | UTC

Embracing complexity: making sense of diet, nutrition, obesity and type 2 diabetes – Diabetologia

 

Commentary on Twitter

Under a http://creativecommons.org/licenses/by/4.0/ license

 


RCT | Ligation of intersphincteric fistulous tract vs. endorectal advancement flap for high-type fistula in ano

28 Feb, 2023 | 13:40h | UTC

Ligation of Intersphincteric Fistulous Tract vs Endorectal Advancement Flap for High-Type Fistula in Ano: A Randomized Controlled Trial – Journal of the American College of Surgeons (link to abstract – $ for full-text)

 

Commentary on Twitter

 


RCT | Effects of an exercise and physical activity program in patients with atrial fibrillation

28 Feb, 2023 | 13:38h | UTC

An Exercise and Physical Activity Program in Patients With Atrial Fibrillation: The ACTIVE-AF Randomized Controlled Trial – JACC: Clinical Electrophysiology (link to abstract – $ for full-text)

Commentary: ACTIVE-AF Suggests Physical Activity May Reduce Atrial Fibrillation Risk – HCP Live

 


SR | Insufficient evidence to recommend Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia

28 Feb, 2023 | 13:39h | UTC

Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia – Cochrane Library

 


Cardiovascular disease related to immune therapy: JACC: CardioOncology special focus issue

28 Feb, 2023 | 13:37h | UTC

Cardiovascular Disease Related to Immune Therapy: JACC: CardioOncology Special Focus Issue – JACC: CardioOncology

Homepage: Special Focus Issue: Immune Therapy

Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art Review

Cancer Immunotherapy Beyond Checkpoint Blockade: JACC: CardioOncology State-of-the-Art Review

Atherosclerosis With Immune Checkpoint Inhibitor Therapy: Evidence, Diagnosis, and Management: JACC: CardioOncology State-of-the-Art Review

Cardiotoxicity of T-Cell Antineoplastic Therapies: JACC: CardioOncology Primer

What Is the Evidence of the Diagnostic Criteria and Screening of Immune Checkpoint Inhibitor–Induced Myocarditis?

The Role of Single-Cell Profiling and Deep Immunophenotyping in Understanding Immune Therapy Cardiotoxicity

Related:

Cardiovascular complications of immune checkpoint inhibitors for cancer – European Heart Journal

Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute—Cancer Therapy Evaluation Program – Journal of Clinical Oncology

Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment – Journal of the American Heart Association

Cardiotoxicity of immune checkpoint inhibitors – ESMO Open

Cardiotoxicity from immune checkpoint inhibitors – IJC Heart & Vasculature

Cardiovascular toxicity of immune checkpoint inhibitors in cancer patients: A review when cardiology meets immuno-oncology – Journal of the Formosan Medical Association

Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock – JACC: CardioOncology

 


Review | Morbidity and mortality after surgery for retroperitoneal sarcoma

28 Feb, 2023 | 13:35h | UTC

Morbidity and Mortality after Surgery for Retroperitoneal Sarcoma – Current Oncology

 


The adult and pediatric palliative care: differences and shared issues

28 Feb, 2023 | 13:30h | UTC

The adult and pediatric palliative care: differences and shared issues – Journal of Anesthesia, Analgesia and Critical Care

 


M-A | Effect of posterior pericardiotomy in cardiac surgery

28 Feb, 2023 | 13:34h | UTC

Effect of posterior pericardiotomy in cardiac surgery: A systematic review and meta-analysis of randomized controlled trials – Frontiers in Cardiovascular Medicine

 


Review | (Mal)nutrition in critical illness and beyond

28 Feb, 2023 | 13:28h | UTC

(Mal)nutrition in critical illness and beyond: a narrative review – Anaesthesia

 


Cluster RCT | Effectiveness of an intensive care telehealth program to improve process quality

28 Feb, 2023 | 13:31h | UTC

Effectiveness of an intensive care telehealth programme to improve process quality (ERIC): a multicentre stepped wedge cluster randomised controlled trial – Intensive Care Medicine

 

Commentary on Twitter

 


Cohort Study | Risk of second primary malignancies in patients with chronic lymphocytic leukemia

28 Feb, 2023 | 13:27h | UTC

Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019 – Blood Cancer Journal

 

Commentary on Twitter

 


RCT | Single-dose psilocybin-assisted therapy in major depressive disorder

28 Feb, 2023 | 13:26h | UTC

Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial – eClinicalMedicine

Commentary: A single, moderate dose of psilocybin reduces depressive symptoms for at least two weeks, controlled study finds – PsyPost

Related:

Phase 2 RCT | Single-dose Psilocybin for a treatment-resistant episode of major depression.

RCT | In patients with alcohol use disorder, the percentage of heavy drinking days was reduced with a psychedelic drug.

Phase 2 RCT: Psilocybin, a psychedelic compound, shows promise for the treatment of depression in a study with 59 patients

Research: “Magic mushrooms” for treatment-resistant depression

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.